Wellington Management Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-533,604
| Closed | -$10.8M | – | 2359 |
|
|
2021
Q3 | $10.8M | Sell |
533,604
-2,765,749
| -84% | -$55.8M | ﹤0.01% | 1256 |
|
|
2021
Q2 | $123M | Sell |
3,299,353
-1,021,547
| -24% | -$38.1M | 0.02% | 576 |
|
|
2021
Q1 | $110M | Buy |
4,320,900
+3,277
| +0.1% | +$83.8K | 0.02% | 586 |
|
|
2020
Q4 | $95.1M | Sell |
4,317,623
-578,530
| -12% | -$12.7M | 0.02% | 602 |
|
|
2020
Q3 | $88.1M | Buy |
4,896,153
+553,984
| +13% | +$9.97M | 0.02% | 553 |
|
|
2020
Q2 | $110M | Buy |
4,342,169
+472,153
| +12% | +$12M | 0.02% | 497 |
|
|
2020
Q1 | $71.1M | Buy |
3,870,016
+3,602,192
| +1,345% | +$66.2M | 0.02% | 538 |
|
|
2019
Q4 | $5.9M | Buy |
+267,824
| New | +$5.9M | ﹤0.01% | 1295 |
|
|
2016
Q3 | – | Sell |
-668,691
| Closed | -$2.01M | – | 2239 |
|
|
2016
Q2 | $2.01M | Sell |
668,691
-1,397,456
| -68% | -$4.19M | ﹤0.01% | 1592 |
|
|
2016
Q1 | $11.1M | Sell |
2,066,147
-365,010
| -15% | -$1.96M | ﹤0.01% | 1112 |
|
|
2015
Q4 | $28.9M | Sell |
2,431,157
-94,011
| -4% | -$1.12M | 0.01% | 841 |
|
|
2015
Q3 | $20.7M | Buy |
2,525,168
+20,646
| +0.8% | +$170K | 0.01% | 947 |
|
|
2015
Q2 | $34.9M | Buy |
2,504,522
+18,675
| +0.8% | +$261K | 0.01% | 830 |
|
|
2015
Q1 | $59.7M | Buy |
2,485,847
+970,545
| +64% | +$23.3M | 0.02% | 678 |
|
|
2014
Q4 | $25M | Buy |
+1,515,302
| New | +$25M | 0.01% | 969 |
|